BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21844136)

  • 1. Do beta-blockers alter dyspnea and fatigue in advanced lung cancer? A retrospective analysis.
    Cameron P; Ellis PM; Pond GR; Goffin JR
    Palliat Med; 2012 Sep; 26(6):797-803. PubMed ID: 21844136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term surgical outcome in patients with lung cancer and coexisting severe COPD.
    Nakajima T; Sekine Y; Yamada Y; Suzuki H; Yasufuku K; Yoshida S; Suzuki M; Shibuya K; Fujisawa T; Yoshino I
    Thorac Cardiovasc Surg; 2009 Sep; 57(6):339-42. PubMed ID: 19707975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A symptom cluster and sentinel symptom experienced by women with lung cancer.
    Brown JK; Cooley ME; Chernecky C; Sarna L
    Oncol Nurs Forum; 2011 Nov; 38(6):E425-35. PubMed ID: 22037342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyspnea in cancer patients. Etiology, resource utilization, and survival-implications in a managed care world.
    Escalante CP; Martin CG; Elting LS; Cantor SB; Harle TS; Price KJ; Kish SK; Manzullo EF; Rubenstein EB
    Cancer; 1996 Sep; 78(6):1314-9. PubMed ID: 8826956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing dyspnea in patients with non-small cell lung cancer in the acute care setting.
    Gaguski ME; Brandsema M; Gernalin L; Martinez E
    Clin J Oncol Nurs; 2010 Aug; 14(4):509-13. PubMed ID: 20682508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise and relaxation intervention for patients with advanced lung cancer: a qualitative feasibility study.
    Adamsen L; Stage M; Laursen J; Rørth M; Quist M
    Scand J Med Sci Sports; 2012 Dec; 22(6):804-15. PubMed ID: 21599754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the differential from complete blood counts as a biomarker of fatigue in advanced non-small-cell lung cancer: an exploratory analysis.
    Paddison JS; Temel JS; Fricchione GL; Pirl WF
    Palliat Support Care; 2009 Jun; 7(2):213-7. PubMed ID: 19538804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical activity as a mediator between dyspnea and fatigue in patients with chronic obstructive pulmonary disease.
    Woo K
    Can J Nurs Res; 2000 Dec; 32(3):85-98. PubMed ID: 11928136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modafinil for the treatment of fatigue in lung cancer: a pilot study.
    Spathis A; Dhillan R; Booden D; Forbes K; Vrotsou K; Fife K
    Palliat Med; 2009 Jun; 23(4):325-31. PubMed ID: 19270033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
    Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
    Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary rehabilitation in non-small cell lung cancer patients after completion of treatment.
    Glattki GP; Manika K; Sichletidis L; Alexe G; Brenke R; Spyratos D
    Am J Clin Oncol; 2012 Apr; 35(2):120-5. PubMed ID: 21378541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of oral topotecan in advanced non-small cell lung cancer.
    White SC; Cheeseman S; Thatcher N; Anderson H; Carrington B; Hearn S; Ross G; Ranson M
    Clin Cancer Res; 2000 Mar; 6(3):868-73. PubMed ID: 10741709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency?
    Paludan M; Traberg Hansen A; Petersen J; Grau C; Høyer M
    Acta Oncol; 2006; 45(7):818-22. PubMed ID: 16982545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyspnea experience in patients with lung cancer in palliative care.
    Henoch I; Bergman B; Gustafsson M; Gaston-Johansson F; Danielson E
    Eur J Oncol Nurs; 2008 Apr; 12(2):86-96. PubMed ID: 18023256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women with lung cancer: quality of life after thoracotomy: a 6-month prospective study.
    Sarna L; Cooley ME; Brown JK; Chernecky C; Padilla G; Danao L; Chakravarty D; Elashoff D
    Cancer Nurs; 2010; 33(2):85-92. PubMed ID: 20142740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of dyspnea in advanced lung cancer: recent data and emerging concepts.
    Xue D; Abernethy AP
    Curr Opin Support Palliat Care; 2010 Jun; 4(2):85-91. PubMed ID: 20440205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer.
    Zimmermann FB; Geinitz H; Schill S; Grosu A; Schratzenstaller U; Molls M; Jeremic B
    Lung Cancer; 2005 Apr; 48(1):107-14. PubMed ID: 15777977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative exploration of a respiratory distress symptom cluster in lung cancer: cough, breathlessness and fatigue.
    Molassiotis A; Lowe M; Blackhall F; Lorigan P
    Lung Cancer; 2011 Jan; 71(1):94-102. PubMed ID: 20439127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual breathlessness trajectories do not match summary trajectories in advanced cancer and chronic obstructive pulmonary disease: results from a longitudinal study.
    Bausewein C; Booth S; Gysels M; Kühnbach R; Haberland B; Higginson IJ
    Palliat Med; 2010 Dec; 24(8):777-86. PubMed ID: 20847087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptom burden in chronic obstructive pulmonary disease and cancer.
    Joshi M; Joshi A; Bartter T
    Curr Opin Pulm Med; 2012 Mar; 18(2):97-103. PubMed ID: 22262138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.